Skip to main content
SpringerLink
Log in

Radiopharmaceuticals: Recent Developments and Trends

  • Chapter
Diagnostic Nuclear Medicine

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 1483 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abram U, Abram S, Schibli R et al (1992) Synthesis and structures of technetium (I) and rhenium (I) tricarbonyl complexes with bis(diphenylthiophosphoryl)amide, {M(CO)3[Ph2PS)2N](CH3CN)}(M=Tc, Re). Polyhedron 17:1303–1309

    Google Scholar 

  • Agdeppa ED, Kepe V, Flores-Torees S et al (2001a) In vitro binding characteristics of FDDNP and a new analog for synthetic [beta]-amyloid fibrils. J Nucl Med 42:64P

    Google Scholar 

  • Agdeppa D, Kepe V, Liu J et al (2001b) Binding characteristics of radiofluorinated 6-dialkylamino-2-naphtylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer’s disease. J Neurosci 21:RC189 (1–5)

    CAS  PubMed  Google Scholar 

  • Agdeppa ED, Kepe V, Shogi-Jadid K et al (2001c) In vivo and in vitro labeling of plaques and tangles in the brain of an Alzheimer’s disease patient: a case study. J Nucl Med 42:65P

    Google Scholar 

  • Agdeppa ED, Kepe V, Petri A et al (2003) In-vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer’s brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl] ethylidene)malononitrile. Neuroscience 117:723–730

    Article  CAS  PubMed  Google Scholar 

  • Alberto R, Welch MJ (2003) Tc(CO)(3)](+) chemistry: a promising new concept for SPET? For and Against. Eur J Nucl Med Mol Imaging 30:1299–1304

    Article  PubMed  Google Scholar 

  • Alberto R, Schibli R, Egli A et al (1998a) Steps towards [(C5-Me5)TcO3] novel synthesis of [C5Me5)Tc(CO)3] from [{Tc(m3-OH)(CO)3}4] and oxidation of [(C5Me)5M(CO)3] (M=Tc,Re) with Br2}. Polyhedron 17:1133–1140

    Article  CAS  Google Scholar 

  • Alberto R, Schibli R, Egli A et al (1998b) A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]− in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc 120:7987–7988

    Article  CAS  Google Scholar 

  • Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73–93

    Article  CAS  PubMed  Google Scholar 

  • Anon (1989) In vitro stabilization of technetium-99m exametazime (HM-PAO). Res Discl 305:666

    Google Scholar 

  • Bakker WH, Brunss AC, Breeman WAP et al (1991a) [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49:1583–1591

    CAS  PubMed  Google Scholar 

  • Bakker WH, Krenning EP, Breeman WAP et al (1991b) In vivo use of radioiodinated somastatin analogue: dynamics, metabolism and binding to somatostatin receptor positive tumors in man. J Nucl Med 32:1184–1189

    CAS  PubMed  Google Scholar 

  • Bakker WH, Krenning EP, Reubi JC et al (1991c) In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci 49:1593–1601

    CAS  PubMed  Google Scholar 

  • Ballinger JR (2001) Imaging hypoxia in tumors. Semin Nucl Med 31:321–329

    CAS  PubMed  Google Scholar 

  • Ballinger JR, Gulenchyn K (1991) Alternative formulations for technetium-99m HMPAO. Int J Appl Radiat Isotop 42:315–316

    CAS  Google Scholar 

  • Ballinger JR, Banneman J, Boxen I et al (1996) Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 37:1578–1582

    CAS  PubMed  Google Scholar 

  • Ballinger JR, Muzzammil T, Moore MJ (1997) Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors. J Nucl Med 38:1915–1919

    CAS  PubMed  Google Scholar 

  • Barclay NA, Birkeland ML, Brown MH et al (eds) (1990) The leukocyte antigen facts book. Academic, New York, p 138

    Google Scholar 

  • Barrio JR, Huang SC, Satyamurthy N et al (1999) PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe. J Labelled Compd Radiopharm 42:S194–S195

    Google Scholar 

  • Bartenstein P, Ludolph A, Schober O et al (1991) Benzodiazepine receptors and cerebral blood flow in partial epilepsy. Eur J Nucl Med 18:111–118

    CAS  PubMed  Google Scholar 

  • Beer HF, Blauenstein PA, Hasler PH et al (1990) In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31:1007–1014

    CAS  PubMed  Google Scholar 

  • Bengel FM, Anton M, Richter T et al (2003) Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer. Circulation 108:2127–2133

    Article  CAS  PubMed  Google Scholar 

  • Berger G, Mazière M, Comar D (1979) Automated synthesis of 11C-labeled radiopharmaceuticals: imipramine, chlorpromazine, nicotine, methionine. Int J Appl Radiat Isot 30:393–399

    Article  CAS  PubMed  Google Scholar 

  • Billinghurst MW, Abrams DN, Lawson MS (1991) Stabilization of [99mTc]HMPAO-1. Ethanolic preparation. Int J Appl Radiat Isotop 42:607–612

    CAS  Google Scholar 

  • Blankenberg FG, Katsikis PD, Tait JF et al (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95:6349–6354

    Article  CAS  PubMed  Google Scholar 

  • Blum J, Handmaker H, Lister-James J et al (2000) A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules. Chest 117:1219–1220

    Article  Google Scholar 

  • Bobeldijk M, Verhoeff NPLG, Vekemans JAJM et al (1990) A simple and high-yield synthesis of (S)-BZM, (R)-BZM and (S)-IBZM for the preparation of (S)-123I-IBZM. J Labeled Compds Radiopharm 28:1247–1256

    CAS  Google Scholar 

  • Boja JW, Carroll FI, Rahman MA et al (1990) New, potent cocaine analogs: ligand binding and transport studies in rat striatum. Eur J Pharm 184:329–332

    CAS  Google Scholar 

  • Bruehlmeier M, Roelcke U, Schubiger PA et al (2004) Assessment of hypoxia and perfusion in human brain tumors using PET with [18F]fluoromisonidazole and [15O]H2O. J Nucl Med 45:1851–1859

    PubMed  Google Scholar 

  • Buchegger F, Bonvin F, Kosinski M et al (2003) Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients. J Nucl Med 44:1649–1654

    CAS  PubMed  Google Scholar 

  • Burch WM, Browitt RJ (1996) The transition from technegas to pertechnegas. J Nucl Med 37:1917–1918

    CAS  PubMed  Google Scholar 

  • Burch WM, Tetley IJ, Gras JL (1984) Technetium-99m ‘Pseudogas ‘for diagnostic studies in the lung. Clin Phys Physiol Meas 5:79–85

    Article  CAS  PubMed  Google Scholar 

  • Burch WM, Sullivan PJ, Lomas FE et al (1986a) Lung ventilation studies with technetium-99m pseudogas. J Nucl Med 27:842–846

    CAS  PubMed  Google Scholar 

  • Burch WM, Sullivan PJ, McLaren CJ (1986b) Technegas — a new ventilation agent for lung scanning. Nucl Med Commun 7:865–871

    CAS  PubMed  Google Scholar 

  • Busatto GF, Pilowsky LS, Costa DC et al (1997) Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. Eur J Nucl Med 24:119–124

    Article  CAS  PubMed  Google Scholar 

  • Carroll FI, Rahman MA, Abraham P et al (1991) [123I]3β-(4-iodophenyl)tropan-2β-carboxylic acid methyl ester (RTI-55), a unique cocaine receptor ligand for imaging the dopamine and serotonin transporters in vivo. Med Chem Res 1:289–294

    CAS  Google Scholar 

  • Cayre A, Cachin F, Maublant J et al (2004) Does 99mTc-sestamibi uptake discriminate breast tumors? Cancer Invest 22:498–504

    Article  CAS  PubMed  Google Scholar 

  • Chou KL, Hurtig HI, Stern MB et al (2004) Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson’s disease. Parkinsonism Relat Disord 10:375–379

    Article  CAS  PubMed  Google Scholar 

  • Cowen P 1991 Serotonin receptor subtypes implications for psychopharmacology. Br J Psychiatry 159[Supp 12]:7–14

    Google Scholar 

  • Crombez D, Van Nerom C, Bormans G et al (1991) Practical aspects of labeling and quality control of Tc-99m MIBI. In: Schmidt HAE, van der Schoot JB (eds) The state of the art of nuclear medicine in Europe. Schattauer, Stuttgart, pp 106–108

    Google Scholar 

  • Danpure HJ, Osman S, Carroll MJ (1988) Development of a clinical protocol for radiolabeling of mixed leukocytes with 99mTc-hexamethylpropyleneamine oxime. Nucl Med Commun 9:465–475

    CAS  PubMed  Google Scholar 

  • Datz FL (1993) The current status of radionuclide infection imaging. In: Freeman LM (ed) Nuclear medicine annual. Raven, New York

    Google Scholar 

  • Datz FL (1994) Indium-111-labeled leukocytes for the detection of infection: current status. Semin Nucl Med 24:92–109

    CAS  PubMed  Google Scholar 

  • Dehdashti F, Grigsby PW, Mintun MA et al (2003) Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response — a preliminary report. Int J Rad Oncol Biol Phys 55:1233–1238

    Article  Google Scholar 

  • Dewanjee MK (1990) The chemistry of 99mTc-labeled radiopharmaceuticals. Semin Nucl Med 20:5–27

    CAS  PubMed  Google Scholar 

  • Dezutter NA, De Groot TJ, Busson RH et al (1999a) Preparation of 99mTc-N2S2 conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer’s disease. J Labelled Compd Radiopharm 42:309–324

    CAS  Google Scholar 

  • Dezutter NA, Dom RJ, De Groot TJ et al (1999b) 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer’s disease. Eur J Nucl Med 26:1392–1399

    Article  CAS  PubMed  Google Scholar 

  • Dumas C, Petrig J, Schibli R et al (2001) Functionalisation of glucose for the labeling with 99mTc-tricarbonyl. J Labelled Compd Radiopharm 44:S57–S59

    Google Scholar 

  • Dumas C, Schibli R, Schubiger PA (2003) Versatile routes to C-2-and C-6-functionalized glucose derivatives of iminodiacetic acid. J Org Chem 68:512–518

    Article  CAS  PubMed  Google Scholar 

  • Dyszlewski ME, Bushman MJ, Alberto R et al (2001) Kit formulation and preliminary toxicity of [99mTc(CO)3]+ intermediate: a novel technetium radiopharmaceutical platform. J Labeled Compd Radiopharm 44:S483–S485

    Google Scholar 

  • Frier M (1994) Leucocyte radiolabelling techniques: practical aspects. Scand J Gastroenterol 29[Suppl]:32–35

    Google Scholar 

  • Gallacher BM, Ansari A, Atkins H et al (1977) Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 18:990–996

    Google Scholar 

  • Grierson IR, Link JM, Mathis CA et al (1989) A radiosynthesis of fluorine-18 fluoromisonidazole. J Nucl Med 30:343–350

    CAS  PubMed  Google Scholar 

  • Grierson JR, Schwartz JL, Muzi M et al (2004) Metabolism of 3‘-deoxy-3‘-[18F]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol 31:829–837

    CAS  PubMed  Google Scholar 

  • Gronroos T, Bentzen L, Marjamaki P et al (2004) Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 31:513–520

    PubMed  Google Scholar 

  • Halldin C, Farde L, Högberg T et al (1991) A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding. Nucl Med Biol 18:871–88

    CAS  Google Scholar 

  • Hamacher K, Coenen HH (2002) Efficient production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine. Appl Rad Isot 57:853–856

    CAS  Google Scholar 

  • Hamacher K, Coenen HH, Stöcklin G et al (1986) Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235–238

    CAS  PubMed  Google Scholar 

  • Hamilton RG, Alderson PO (1977) A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99mTc]pertechnetate. J Nucl Med 18:1010–1013

    CAS  PubMed  Google Scholar 

  • Han G, Cho CG, Lansbury PT (1996) Technetium complexes for the quantitation of brain amyloid. J Am Chem Soc 118:4506–4507

    CAS  Google Scholar 

  • Hansen HJ, Jones AL, Sharkey RM et al (1990) Preclinical evaluation of an “instant” 99mTc-labeling kit for antibody imaging. Cancer Res [Suppl] 50:794s–798s

    CAS  PubMed  Google Scholar 

  • Hantraye P, Kaijima M, Prenant C et al (1984) Central type benzodiazepine binding sites: a positron emission tomography study in the baboon’s brain. Neuroscience Lett 48:115–120

    Article  CAS  Google Scholar 

  • Hartmann IJ, Hagen PJ, Stokkel MP et al (2001) Technegas versus 81mKr ventilation-perfusion scintigraphy: a comparative study in patients with suspected acute pulmonary embolism. J Nucl Med 42:393–400

    CAS  PubMed  Google Scholar 

  • Hegge FN, Hamilton GW, Larson SM et al (1978) Cardiac chamber imaging: a comparison of red blood cells, labeled with Tc-99m in vitro and in vivo. J Nucl Med 19:129–134

    CAS  PubMed  Google Scholar 

  • Henry C, Koumanov F, Ghezzi C et al (1995) Experimental models, protocols, and reference values for evaluation of iodinated analogues of glucose. Nucl Med Biol 22:875–885

    CAS  PubMed  Google Scholar 

  • Higley B, Smith FW, Smith T et al (1993) Technetium-99m-1,2 bis[bis(2-ethoxyethyl)phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 34:30–38

    CAS  PubMed  Google Scholar 

  • Hoepping A, Reisgys M, Brust P et al TROTEC-1 (1998) A new high-affinity ligand for labeling of the dopamine transporter. J Med Chem 41:4429–4432

    Article  CAS  PubMed  Google Scholar 

  • Hoffend J, Mier W, Schmidt K et al (2004) In vivo characterization of gallium-68-DOTA-albumin, a generator-produced PET blood-pool tracer. Eur J Nucl Med Mol Imaging 31:S257–S258

    Google Scholar 

  • Högberg T, Ström P, de Paulis T et al (1991) Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-((1-benzyl-2-pyrrolidinyl)methyl)benzamides. Relation to other side chain congeners. J Med Chem 34:948–955

    PubMed  Google Scholar 

  • Hoyer D, Clarke D, Fozard J et al (1994) International union of pharmacology classification of receptors for 5-hydroxytrypamine. Pharmacol Rev 46:157–203

    CAS  PubMed  Google Scholar 

  • Huang TY, Hwang DR, Narendran R et al (2002) Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652. J Cereb Blood Flow Metab 22:1377–1398

    CAS  PubMed  Google Scholar 

  • Huang WS, Lee MS, Lin JC et al (2004) Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson’s disease. Eur J Nucl Med Mol Imaging 31:155–161

    Article  PubMed  Google Scholar 

  • Hung JC, Gibbons RJ (1992) Breakage of technetium-99m-sestamibi vial with the use of a microwave oven. J Nucl Med 33:176–178

    CAS  PubMed  Google Scholar 

  • Hung JC, Volkert WA, Holmes RA (1989) Stabilization of technetium-99m-d,l-hexamethylpropyleneamine oxime (99mTc-d, l-HM-PAO) using gentisic acid. Nucl Med Biol 16:675–680

    CAS  Google Scholar 

  • Hung JC, Wilson ME, Brown ML et al (1991) Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (Technetium-99m-sestamibi). J Nucl Med 32:2162–2168

    CAS  PubMed  Google Scholar 

  • Hung JC, Chowdhury S, Redfern MG et al (1997) Rapid preparation method for technetium-99m-bicisate. Eur J Nucl Med 24:655–659

    CAS  PubMed  Google Scholar 

  • Iqbal T, Cain JH, Slosky JJ (1989) Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes for scintigraphy. PCT Int Appl WO 8902,433

    Google Scholar 

  • Ishiwata K, Vaalburg W, Elsinga PH et al (1988) Comparison of l-[1-11C]methionine and l-methyl-[11C]methionine for measurement of in vivo protein synthesis rate with PET. J Nucl Med 29:1419–1427

    CAS  PubMed  Google Scholar 

  • Johnson EW, Woods SW, Zoghbi SS et al (1990) Receptor binding characterization of the benzodiazepine radioligand 125I-Ro 16-0154: potential probe for SPECT brain imaging. Life Sci 47:1535–1546

    Article  CAS  PubMed  Google Scholar 

  • Kaufman MJ, Madras BK (1991) Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson’s diseased striatum. Synapse 49:43–49

    Google Scholar 

  • Kawai K, Fujibayashi Y, Saji H et al (1991) A strategy for the study of cerebral amino acid transport using iodine-123 labeled amino acid radiopharmaceutical: 3-iodo-alphamethyl-l-tyrosine. J Nucl Med 32:819–824

    CAS  PubMed  Google Scholar 

  • Kemerink GJ, Liem IH, Dumont EA et al (2001a) Patient dosimetry of intravenously administered 99mTc-annexin V. J Nucl Med 42:382–387

    CAS  PubMed  Google Scholar 

  • Kemerink GJ, Boersma HH, Thimister PWL et al (2001b) Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans. Eur J Nucl Med 28:1373–1378

    Article  CAS  PubMed  Google Scholar 

  • Kemerink GJ, Liu X, Kieffer D et al (2003) Safety, biodistribution, and dosimetry of 99mTc-Hynic-Annexin V, a novel human recombinant Annexin V for human application. J Nucl Med 44:947–952

    CAS  PubMed  Google Scholar 

  • Klimek V, Stockmeier C, Overholser J et al (1997) Reduced levels of norepineprine transporters in the locus coeruleus in major depression. J Neurosc 17:8451–8458

    CAS  Google Scholar 

  • Kloss G, Leven M (1979) Accumulation of radioiodinated tyrosine derivatives in adrenal medulla and in melanomas. Eur J Nucl Med 4:179–186

    Article  CAS  PubMed  Google Scholar 

  • Klunk WE, Wang Y, Huang G et al (2001) Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69:1471–1484

    Article  CAS  PubMed  Google Scholar 

  • Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 55:306–319

    Article  CAS  PubMed  Google Scholar 

  • Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497

    CAS  PubMed  Google Scholar 

  • Krasikova RN, Ryzhikov NN, Gomzina NA et al (2004) One-step synthesis of n.c.a. [18F]flumazenil and a preliminary evaluation in monkey by PET. Eur J Nucl Med Mol Imaging 31:S249

    Google Scholar 

  • Krenning EP, Bakker WH, Kooij PPM et al (1992) Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 33:652–658

    CAS  PubMed  Google Scholar 

  • Kung HF, Guoy Z, Billings D (1988) Preparation and biodistribution of [123I]IBZM: a potential CNS D2 dopamine receptor imaging agent. Nucl Med Biol 15:195–201

    CAS  Google Scholar 

  • Kung HF, Alavi A, Chang W et al (1990) In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. J Nucl Med 31:573–579

    CAS  PubMed  Google Scholar 

  • Kung HF, Kim H-J, Kung M-P et al (1996) Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 23:1527–1530

    Article  CAS  PubMed  Google Scholar 

  • Kung M-P, Stevenson DA, Plössi K et al (1997) [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 24:372–380

    CAS  PubMed  Google Scholar 

  • Lahorte CMM, Vanderheyden J-L, Steinmetz N et al (2004) Apoptose-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging 31:887–919

    CAS  PubMed  Google Scholar 

  • Laihinen AO, Rinne JO, Nägren K et al (1995) PET studies on brain monoamine transporters with carbon-11-β-CIT in Parkinson’s disease. J Nucl Med 36:1263–1267

    CAS  PubMed  Google Scholar 

  • Lang J, Barbarics E, Lazar J et al (1989) Effects of labeling conditions and formulation of kit on in vitro stability of 99mTc-d,l-HM-PAO. Eur J Nucl Med 15:424

    Google Scholar 

  • Langen K-J, Coenen HH, Roosen N et al (1990) SPECT studies of brain tumors wirh L-3-[123I]iodo-α-methyl tyrosine: comparison with PET, 124IMT and first clinical results. J Nucl Med 31:281–286

    CAS  PubMed  Google Scholar 

  • Langen K-J, Roosen N, Coenen HH et al (1991) Brain and brain tumor uptake of L-3-[123I]iodo-α-methyl tyrosine: competition with natural L-amino acids. J Nucl Med 32:1225–1228

    CAS  PubMed  Google Scholar 

  • Langström B, Antoni G, Gullberg P et al (1987) Synthesis of L-and D-[methyl-11C]methionine. J Nucl Med 28:1037–1040

    PubMed  Google Scholar 

  • Lehtiö K, Eskola O, Viljanen T et al (2004) Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys 59:971–982

    PubMed  Google Scholar 

  • Lemaire C, Cantineau R, Guillaume M et al (1991) Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 32:2266–2272

    CAS  PubMed  Google Scholar 

  • Lemb M, Oei TH, Eifert H et al (1993) Technegas: a study of particle structure, size and distribution. Eur J Nucl Med 20:576–579

    Article  CAS  PubMed  Google Scholar 

  • Lewis JS, McCarthy DW, McCarthy TJ et al (1999) Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med 40:177–183

    CAS  PubMed  Google Scholar 

  • Leysen JE (1989) Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites. In: Boulton AB, Baker BG, Jurio AV (eds) Drugs as tools in neurotransmitter research. Humana Press, Clifton, NJ, pp 299–349 (Neuromethods, vol 12)

    Google Scholar 

  • Lin JL, Berridge M (1993) An efficient radiosynthesis of [18F]fluoromisonidazole. Appl Rad Isot 44:1085–1091

    Google Scholar 

  • Link CD, Johnson CJ, Fonte V et al (2001) Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging 22:217–226

    Article  CAS  PubMed  Google Scholar 

  • Lister-James J, Knight LC, Mauer AH et al (1996) Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide. J Nucl Med 37:775–781

    CAS  PubMed  Google Scholar 

  • Litton J, Farde L, Neiman J et al (1991) Positron emission tomography of benzodiazepine receptor binding in alcoholics — equilibrium quantification. J Cerebr Blood Flow Metab 11[Suppl]:617

    Google Scholar 

  • Mackey DW, Jackson P, Baker RJ et al (1994) The observation of fullerenes in a Technegas lung ventilation unit. Nucl Med Commun 15:430–434

    CAS  PubMed  Google Scholar 

  • Mang’era KO, Vanbilloen HP, Schiepers CW et al (1995) Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour. Eur J Nucl Med 22:1163–1172

    CAS  PubMed  Google Scholar 

  • Mang’era KO, Vanbilloen HP, Bellande E et al (1996) Influence of a 99mTcN core on the biological and physicochemical behavior of 99mTc complexes of l,l-EC and l,l-ECD. Nucl Med Biol 23:987–993

    CAS  PubMed  Google Scholar 

  • Mangner TJ, Klecker RW, Anderson L et al (2003) Synthesis of 2 ‘-deoxy-2 ‘-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation-Synthesis of [18F]labeled FAU, FMAU, FBAU, FIAU. Nucl Med Biol 30:215–224

    CAS  PubMed  Google Scholar 

  • Marmion ME, Bugaj JE, Schmidt MA et al (2000) Preparation and biological evaluation of 99mTc(I)-carbonyl labeled octreotate conjugates. J Nucl Med 41:156P

    Google Scholar 

  • Martin SJ, Reutelingsperger CPM, McGahon AJ et al (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545–1556

    Article  CAS  PubMed  Google Scholar 

  • Martin SJ, Eisenbarth JA, Wagner-Utermann U et al (2002) A new precursor for the radiosynthesis of [18F]FLT. N ucl Med Biol 29:263–273

    CAS  Google Scholar 

  • Mathis CA, Wang Y, Holt DP et al (2003) Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46:2740–2754

    Article  CAS  PubMed  Google Scholar 

  • Mazière M, Godot JM, Berger G et al (1980) High specific activity carbon-11 labelling of benzodiazepines: diazepam and flunitrazepam. J Radioanal Chem 56:229–235

    Google Scholar 

  • Mazière B, Crouzel C, Venet M et al (1988) Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. Nucl Med Biol 15:463–468

    Google Scholar 

  • Mazière B, Coenen HH, Halldin C et al (1992) PET radioligands for dopamine receptors and re-uptake sites: chemistry and biochemistry. Nucl Med Biol 19:497–512

    Google Scholar 

  • McAfee JG, Thakur ML (1976) Survey of radioactive agents for in vitro labelling of phagocytic leukocytes. I. Soluble agents. J Nucl Med 17:480–487

    CAS  PubMed  Google Scholar 

  • McAfee JG, Subramanian JG, Gagne G (1984) Techniques of leucocyte harvesting and labeling: problems and perspectives. Semin Nucl Med 14:83–106

    CAS  PubMed  Google Scholar 

  • Meegalla SK, Plössi K, Kung M-P et al (1997) Synthesis and characterization of Tc-99m labeled tropanes as dopamine tansporter imaging agents. J Med Chem 40:9–17

    Article  CAS  PubMed  Google Scholar 

  • Mertens J, Terriere D, Sipido V et al (1994) Radiosynthesis of a new radioiodinated ligand for serotonin-5HT2-receptors, a promising tracer for γ-emission tomography. J Labelled Compd Radiopharm 34:795–806

    CAS  Google Scholar 

  • Meyer GJ, Macke H, Schuhmacher J et al (2004) Ga-68-labelled DOTA-derivatised peptide ligands. Eur J Nucl Med Mol Imaging 31:1097–1104

    Article  CAS  PubMed  Google Scholar 

  • Meyer JH, Wilson A, Sagrati S et al (2004) Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 161:826–835

    Article  PubMed  Google Scholar 

  • Mier W, Haberkorn U, Eisenhut M (2002) [18F]FLT; a portrait of a proliferation marker. Eur J Nucl Med Mol Imaging 29:165–169

    CAS  PubMed  Google Scholar 

  • Mitterhauser M, Wadsak W, Wabnegger L et al (2004) Biological evaluation of 2‘-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET. Nucl Med Biol 31:291–295

    CAS  PubMed  Google Scholar 

  • Monaghan P, Provan I, Murray C (1991) An improved radionuclide technique for the detection of altered pulmonary permeability. J Nucl Med 32:1945–1949

    CAS  PubMed  Google Scholar 

  • Mortelmans L, Malbrain S, Stuyck J et al (1989) In vitro and in vivo evaluation of granulocyte labeling with (99mTc)d,l-HMPAO. J Nucl Med 30:2022–2028

    CAS  PubMed  Google Scholar 

  • Murakami Y, Takamatsu H, Taki J et al (2004) 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 31:469–474

    Article  CAS  PubMed  Google Scholar 

  • Nakayama M, Haratake M, Ono M et al (2003) A new Ge-68/Ga-68 generator system using an organic polymer containing N-methylglucamine groups as adsorbent for Ge-68. Appl Rad Isot 58:9–14

    CAS  Google Scholar 

  • Ohtsuki K, Akashi K, Aoka Y et al (1999) Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis. Eur J Nucl Med 26:1251–1258

    Article  CAS  PubMed  Google Scholar 

  • Okada T, Fujita M, Shimada S et al (1998) Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for mono-amine transporters permanently expressed in cell lines. Nucl Med Biol 25:53–58

    CAS  PubMed  Google Scholar 

  • Oliveira AJ, da Costa JC, Hilario LN et al (1999) Localization of the epileptogenic zone by ictal and interictal SPECT with 99mTc-ethyl cysteinate dimer in patients with medically refractory epilepsy. Epilepsia 40:693–702

    Article  CAS  PubMed  Google Scholar 

  • Olsson H, Halldin C, Farde L (2004) Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage 22:794–803

    Article  PubMed  Google Scholar 

  • Ono M, Wilson A, Nobrega J et al (2003) 11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer’s disease. Nucl Med Biol 30:565–571

    CAS  PubMed  Google Scholar 

  • Osman S, Lundkvist C, Pike V et al (1996) Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand [O-methyl-11C]WAY-100635 in monkey and human plasma by HPLC-comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Nucl Med Biol 23:627–634

    CAS  PubMed  Google Scholar 

  • Pardridge WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 28:103–108

    CAS  PubMed  Google Scholar 

  • Patt YZ, Podoloff DA, Curley S et al (1994) Technetium-99m labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels. J Clin Oncol 12:489–495

    CAS  PubMed  Google Scholar 

  • Pearson DA, Lister-James J, McBride WJ et al (1996) Thrombus imaging using technetium-99m labeled high potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies. J Med Chem 39:1372–1382

    CAS  PubMed  Google Scholar 

  • Peremans K, Audenaert K, Coopman F et al (2003a) Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150. Eur J Nucl Med Mol Imaging 30:1538–1546

    CAS  PubMed  Google Scholar 

  • Peremans K, Audenaert K, Coopman F et al (2003b) Regional binding index of the radiolabeled selective 5-HT2A antagonist 123I-5-I-R91150 in the normal canine brain imaged with single photon emission computed tomography. Vet Radiol Ultrasound 44:344–51

    Article  CAS  PubMed  Google Scholar 

  • Peters AM (1994) Quality control of radiolabelled white cells. In: Martin-Comin J, Thakur ML, Piera C, Roca M, Lomena F (eds) Radiolabeled blood elements. Recent advances in techniques and applications. Plenum, New York, pp 29–32

    Google Scholar 

  • Peters AM, Danpure HJ, Osman S et al (1986) Preliminary clinical experience with 99mTc-HMPAO for labelling leucocytes and imaging inflammation. Lancet 2:946–949

    CAS  PubMed  Google Scholar 

  • Peters AM, Roddie ME, Danpure HJ et al (1988) 99mTc HMPAO labelled leucocytes: a comparison with In-111-tropolonate labelled granulocytes. Nucl Med Commun 9:449–463

    CAS  PubMed  Google Scholar 

  • Picwnica-Worms D, Chiu ML, Budding M et al (1993) Functional imaging of multidrug-resistant P-glycoprotein with an organo-technetium complex. Cancer Res 53:977–984

    Google Scholar 

  • Phelps ME, Hoffman EJ, Selin C et al (1978) Investigation of [18F]-2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med 19:1311–1319

    CAS  PubMed  Google Scholar 

  • Pike VW, McCarron J, Hume SP et al (1995) Preclinical development of a radioligand for studies of central 5-HT1A receptors in vivo — [11C]WAY-100635. Med Chem Res 5:208–227

    CAS  Google Scholar 

  • Pike VW, McCarron J, Lamertsmaa A et al (1996) Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635. Eur J Pharmacol 301:R5–R7

    Article  CAS  PubMed  Google Scholar 

  • Pullman W, Hanna R, Sullivan P et al (1986) 99mTc autologous phagocyte scanning: a new imaging technique for inflammatory bowel disease. Br Med J 293:171–174

    CAS  Google Scholar 

  • Ramalingam K (1989) Facile synthesis of 2-methoxyisobutylisonitrile. Synth Commun 21:511–514

    CAS  Google Scholar 

  • Reutelingsperger CPM, Kop JMM, Hornstra G et al (1988) Purification and characterization of a novel protein from bovine aorta that inhibits coagulation: inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur J biochem 173:171–178

    Article  CAS  PubMed  Google Scholar 

  • Rizzo-Padoin N, Farina A, Le Pen C et al (2001) A comparison of radiopharmaceutical agents used for the diagnosis of pulmonary embolism. Nucl Med Commun 22:375–381

    Article  CAS  PubMed  Google Scholar 

  • Roddie ME, Peters HM, Danpure HJ et al (1988) Imaging inflammation with 99mTchexamethyl propyleneamineoxime (HMPAO) labelled leucocytes. Radiology 166:767–772

    CAS  PubMed  Google Scholar 

  • Rodwell JD, Alvarez VL, Lee C et al (1986) Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations. Proc Natl Acad Sci USA 83:2632–2636

    CAS  PubMed  Google Scholar 

  • Sachdev SS, Ramamoorthy N, Nayak UN et al (1990) Preparation and evaluation of 99mTc-t-butylisonitrile (99mTc-TBI) for myocardial imaging: a kit for hospital radiopharmacy. Nucl Med Biol 17:543–552

    CAS  Google Scholar 

  • Sampson CB, Solanki C (1991) Stabilisation of Tc-99m-exametazine using ethanol and storage at low temperature. Eur J Nucl Med 18:532

    Google Scholar 

  • Samson Y, Bernuau J, Pappata S et al (1987) Cerebral uptake of benzodiazepine measured by positron emission tomography in hepatic encephalopathy. N Engl J Med 316:414–415

    CAS  PubMed  Google Scholar 

  • Savic I, Roland P, Sedvall G et al (1988) In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 16:863–866

    Google Scholar 

  • Scalzetti EM, Gagne GM (1995) The transition from technegas to pertechnegas. J Nucl Med 36:267–269

    CAS  PubMed  Google Scholar 

  • Schauwecker DS, Burt RW, Park HM et al (1988) Comparison of purified indium-111 granulocytes and indium-111 mixed leukocytes for imaging of infections. J Nucl Med 29:23–25

    CAS  PubMed  Google Scholar 

  • Schibli R, Alberto R, Abram U et al (1998) Structural and 99Tc NMR investigations of complexes with fac-[Tc(CO)3]+ moieties and macrocyclic thioethers of various ring sizes: synthesis and x-ray structure of the complexes fac-[Tc(9-ane-S3)(CO)3]Br, fac-[Tc2(tosylate)2(18-ane-S6)(CO)6] and fac-[Tc2(20-ane-S6-OH)(CO)6][tosylate]2. Inorg Chem 37:3509–3516

    CAS  PubMed  Google Scholar 

  • Schibli R, La Bella R, Alberto R et al (2000) Influence of the denticity of ligand systems on the in vitro and in vivo behavior of 99mTc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjug Chem 11:345–351

    Article  CAS  PubMed  Google Scholar 

  • Schou M, Halldin C, Sóvágó J et al (2003) Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER. Nucl Med Biol 30:707–714

    CAS  PubMed  Google Scholar 

  • Schou M, Halldin C, Sóvágó J et al (2004) PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 53:57–67

    Article  CAS  PubMed  Google Scholar 

  • Schroth HJ, Oberhausen E, Berberich R (1981) Cell labelling with colloidal substances in whole blood. Eur J Nucl Med 6:469–472

    Article  CAS  PubMed  Google Scholar 

  • Seabold JE, Forstrom LA, Schauwecker DS et al (1997) Procedure guideline for indium-111-leukocyte scintigraphy for suspected infection/inflammation. J Nucl Med 38:997–1001

    CAS  PubMed  Google Scholar 

  • Selkoe DJ (1999) Biology of β-amyloid precursor protein and the mechanism of Alzheimer’s disease. In: Alzheimer’s disease. Lippincott, Williams and Wilkins, Philadelphia, pp 293–310

    Google Scholar 

  • Shiue GG, Shiue CY, Lee RL et al (2001) A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapy. Nucl Med Biol 28:875–883

    CAS  PubMed  Google Scholar 

  • Shoghi-Jadid K, Small GW, Agdeppa ED et al (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10:24–35

    PubMed  Google Scholar 

  • Slifstein M, Hwang DR, Huang YY et al (2004) In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D-2 receptors in nonhuman primates. Psychopharmacology 175:274–286

    Article  CAS  PubMed  Google Scholar 

  • Small GW, Agdeppa ED, Kepe V et al (2002) In-vivo brain imaging of tangle burden in humans. J Mol Neurosci 19:323–327

    CAS  PubMed  Google Scholar 

  • Sorger D, Patt M, Kumar P et al (2003) [18F]Fluoroazomycin arabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 30:317–326

    CAS  PubMed  Google Scholar 

  • Spanu A, Schillaci O, Meloni GB et al (2002) The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas. Int J Oncol 21:831–840

    PubMed  Google Scholar 

  • Srivastava SC, Babich JB, Richards P (1983) A new kit method for the selective labeling of erythrocytes in whole blood with technetium-99m. J Nucl Med 24:128P

    Google Scholar 

  • Stypinski D, McQuarrie SA, Wiebe LI et al (2001) Dosimetry estimations for 123I-IAZA in healthy volunteers. J Nucl Med 42:1418–1423

    CAS  PubMed  Google Scholar 

  • Terriere D, Janssen PMF, Gommeren W et al (1995) Evaluation of radioiodo-4-amino-N-[1-[3-(4-fluorophenoxy)-propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide as a potential 5HT2 receptor tracer for SPE(C)T. Nucl Med Biol 22:1005–1010

    CAS  PubMed  Google Scholar 

  • Thakur ML Lavender JP, Arnot RN et al (1977) Indium-111-labeled autologous leukocytes in man. J Nucl Med 18:1014–1019

    CAS  PubMed  Google Scholar 

  • Thakur ML, Marcus CS, Henneman P et al (1996) Imaging inflammatory diseases with neutrophil-specific technetium-99m-labeled monoclonal antibody anti-SSEA-1. J Nucl Med 37:1789–1795

    CAS  PubMed  Google Scholar 

  • Tjuvajev JG, Doubrovin M, Akhurst T et al (2002) Comparison of radiolabeled nucleoside probes FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 43:1072–1083

    PubMed  Google Scholar 

  • Tominaga S, Shimada T, Kawakami K (1995) Physicochemical characterization and lung clearance of pertechnegas. Kaku Ikagu 32:563–567

    CAS  Google Scholar 

  • Tubergen K, Corlija M, Volkert WA et al (1991) Sensitivity of technetium-99m-d,l-HMPAO to radiolysis in aqueous solutions. J Nucl Med 32:111–115

    CAS  PubMed  Google Scholar 

  • Tweedle MF (1983) Accelerators for forming cationic technetium complexes useful as radiodiagnostic agents. World Patent 8302:615

    Google Scholar 

  • Vallabhajosula S, Moyer BR, Lister-James J et al (1996) Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med 37:1016–1022

    CAS  PubMed  Google Scholar 

  • Vander Borght T, De Maeght S, Labar D et al (1992) Comparison of thymidine labeled in methyl group and in 2C-ring position in human PET studies. Eur J Nucl Med 19:578

    Google Scholar 

  • Van Paesschen W (2004) Ictal SPECT. Epilepsia 45[Suppl 4]:35–40

    PubMed  Google Scholar 

  • Van Paesschen W, Dupont P, Van Heerden B et al (2000) Self-injection ictal SPECT during partial seizures. Neurology 23:1994–1997

    Google Scholar 

  • Verbeke K, Kieffer D, Vanderheyden J-L et al (2003) Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use. Nucl Med Biol 30:771–778

    CAS  PubMed  Google Scholar 

  • Verhoeff NP, Wilson AA, Takeshita S et al (2004) In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 12:584–595

    PubMed  Google Scholar 

  • Versijpt J, van Laere KJ, Dumont F et al (2003) Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings. Neurobiol Aging 24:553–561

    Article  CAS  PubMed  Google Scholar 

  • Virgolini I, Szilvasi I, Kurtaran A et al (1998) Indium-111-DOTA-Lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients. J Nucl Med 39:1928–1936

    CAS  PubMed  Google Scholar 

  • Wackers FJT, Berman DS, Maddahi J et al (1989) Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30:301–311

    CAS  PubMed  Google Scholar 

  • Waibel R, Alberto R, Willunda J et al (1999) Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 17:897–901

    CAS  PubMed  Google Scholar 

  • Weber W, Weste HJ, Grosu AL et al (2000) O-(2-[18F]Fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 27:542–549

    Article  CAS  PubMed  Google Scholar 

  • Weisner PS, Bower GR, Dollimore LA et al (1993) A method for stabilising technetium-99m exametazime prepared from a commercial kit. Eur J Nucl Med 20:661–666

    Article  CAS  PubMed  Google Scholar 

  • Wester HJ, Herz M, Weber W et al (1999) Synthesis and radio-pharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40:205–212

    CAS  PubMed  Google Scholar 

  • Wienhard K, Herholz K, Coenen HH (1991) Increased amino acid transport into brain tumors measured by PET of 2-[18F]fluorotyrosine. J Nucl Med 32:1338–1346

    CAS  PubMed  Google Scholar 

  • Wust F, Carlson KE, Katzenellenbogen JA et al (1998) Synthesis and binding affinities of new 17 alpha-substituted estradiol-rhenium “n+1” mixed-ligand and thioether-carbonyl complexes. Steroids 63:665–671

    CAS  PubMed  Google Scholar 

  • Yamamoto YL, Meyer E, Menon D et al (1983) Regional cerebral blood measurement and dynamic positron emission tomography. In: Heiss WD, Phelps ME (eds) Positron emission tomography of the brain. Springer, Berlin Heidelberg New York, pp 78–84

    Google Scholar 

  • Yamasaki T, Inoue O, Shinotoh H et al (1986) Benzodiazepine study in the elderly using PET and clinical application of a new tracer, C-11-α-methyl-N-methyl benzylamine. In: Kitane K (ed) Liver and aging, liver and brain. Elsevier, Amsterdam, pp 265–276

    Google Scholar 

  • Yang DJ, Wallace S, Cherif A et al (1995) Development of 18F labeled fluoroerythromisonidazole as a PET agent for imaging tumor hypoxia. Radiology 194:795–800

    CAS  PubMed  Google Scholar 

  • Zhuang ZP, Kung MP, Hou C et al (2001a) Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J Med Chem 44:1905–1914

    Article  CAS  PubMed  Google Scholar 

  • Zhuang ZP, Kung MP, Hou C et al (2001b) IBOX (2-(4‘-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl Med Biol 28:887–894

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiopharmacy Department, UZ Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium

    Guy Bormans PhD, Kristin Verbeke PhD & Alfons Verbruggen PhD

Authors
  1. Guy Bormans PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristin Verbeke PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alfons Verbruggen PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Leuven, Germany

    A. L. Baert

  2. Heidelberg, Germany

    K. Sartor

  3. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, AR-144 CHS, Los Angeles, CA, 90095-6942, USA

    Christiaan Schiepers MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bormans, G., Verbeke, K., Verbruggen, A. (2006). Radiopharmaceuticals: Recent Developments and Trends. In: Baert, A.L., Sartor, K., Schiepers, C. (eds) Diagnostic Nuclear Medicine. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30005-8_15

Download citation

  • DOI: https://doi.org/10.1007/3-540-30005-8_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42309-6

  • Online ISBN: 978-3-540-30005-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation